Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

ancylostomiasis - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

ancylostomiasis

MONDO:0005645

Also known as:hookworm infectionAncylostoma caused disease or disorderAncylostoma disease or disorder

Find Clinical TrialsTrials

Overview

Infection by hookworms of the genus Ancylostoma.

TreatmentsNo approved treatments · 1 in pipeline

Clinical Trials4 registered · 1 recruiting

Diagnosis

Biomarker and diagnostic research for ancylostomiasis has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for ancylostomiasis. An additional 1 compound holds orphan drug designation.

Orphan Drug Designations

While no drugs are FDA-approved specifically for ancylostomiasis, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.

The following drugs have received orphan drug designation from the FDA for ancylostomiasis. Orphan designation reflects regulatory interest and does not indicate approval for treatment.

Brand Name	Generic Name	Sponsor

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

4 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and biologic therapy. Pipeline includes 3 PHASE3, 1 PHASE1. Research is primarily sponsored by academic and government institutions.

184 publications have been identified in PubMed for ancylostomiasis. Research spans Review / Meta-Analysis (32%), Basic Science / Preclinical (22%), and Epidemiology / Natural History (19%).

Research Type	Count	% of Total
Research summaries	48

Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 12:59 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:78

GARD

Genetic and Rare Diseases Info Center

GARD:9742

Questions for Your Care Team

→Are any of the 4 active clinical trials a good fit for my situation?
→What is the current development status of flubendazole, and when might it become available?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

ancylostomiasis

Overview

Diagnosis

Treatment

Orphan Drug Designations

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications